can compounders still make tirzepatide Update: On December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On FDA says years-long tirzepatide shortage

8% w porwnaniu do ~2,6% w grupie placebo, a u 1/3 pacjentw uzyskano 10% utraty wagi (Once-Weekly Semaglutide in Adults with Overweight or Obesity PubMed)

list as of April 2026

Orforglipron vs Semaglutide: Oral GLP-1 Small Molecule vs Proven Peptide Evidence-based comparison of orforglipron and semaglutide for weight loss and type 2 diabetes, including ATTAIN, ACHIEVE-3, and STEP trial data

Liraglutide, the active compound in Victoza, belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists

Dhurandhar, PhD, is Chief Scientific Officer of Obthera, Inc., where she has overseen the dietary treatment of more than 2,500 people with obesity

Conclusion Missing a dose of medication can feel like a setback, but with Zepbound, you have a generous window of flexibility